Therapeutic Innovation Australia is a national consortium of translational research infrastructure. 
Through TIA, Australian researchers from the public and private sector can access a range of expertise and services to assist in the development of new therapeutic products.
The TIA Consortium includes national and international expertise in the development of small molecule pharmaceuticals, biologics & vaccines and cell & gene therapies.

26 Feb 2021

 

 

TIA Pipeline Accelerator 2020-21 ( Round 1) outcomes and launch of Round 2 

Therapeutic Innovation Australia (TIA) is pleased to announce the recipients of the first round of the Pipeline Accelerator 2020-21 scheme, and the launch of Round 2.

Contact us

+61 (07) 3735 4433

NCRIS-PROVIDER-RGB-REV.png

Subscribe to our newsletter to stay up-to-date on the latest news and events